Celixir

About:

Celixir is a unique technology platform drives in-house discovery and manufacturing.

Website: http://www.celixir.com/

Twitter/X: celixirltd

Top Investors: Angels 5K

Description:

Celixir is a developer of regenerative medicines created to change the lives of patients in need. The company's medicines consists of iMP cells, platelet lysate and PML cells to treat patients with ischaemic heart disease, injured tendons near the surface of the skin and mild to moderate heart failure respectively, enabling medical researchers to discover breakthrough medicines that aim to change the standard of medical care for patients.

Total Funding Amount:

$2.62M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Cardiff, Cardiff, United Kingdom

Founded Date:

2009-01-01

Contact Email:

info(AT)celltherapyltd.com

Founders:

Ajan Reginald

Number of Employees:

11-50

Last Funding Date:

2018-03-21

IPO Status:

Private

Industries:

© 2025 bioDAO.ai